Lin Dang
Overview
Explore the profile of Lin Dang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Shi J, Hou S, Kang X, Yu C, Jin H, et al.
Sci Rep
. 2024 Oct;
14(1):25749.
PMID: 39468139
Severe psoriasis has a long course and poor outcome, and it has long been a problem for patients. Understanding the independent risk factors that contribute to patients with severe psoriasis...
2.
Tang N, Li Y, Tang J, Chen J, Chen L, Dang L
Acta Histochem
. 2024 Aug;
126(5-7):152186.
PMID: 39142244
Cutaneous melanoma (cM) is a prevalent invasive cancer resulting from the malignant transformation of melanocytes. At present, the primary treatment for melanoma is surgical resection, which is not appropriate for...
3.
Jiao L, Shen T, Han Y, Liu W, Liu W, Dang L, et al.
BMC Infect Dis
. 2024 Aug;
24(1):811.
PMID: 39129008
Objectives: Hepatitis B is a liver disease caused by Hepatitis B virus (HBV) infection and is highly prevalent in China. To better understand the epidemiological characteristics of hepatitis B in...
4.
Supramolecular Nano-Tracker for Real-Time Tracking of Drug Release and Efficient Combination Therapy
Chen X, Chen F, Lu Y, Li Q, Li S, Zheng C, et al.
Adv Sci (Weinh)
. 2024 Jul;
11(36):e2404731.
PMID: 39072943
Real-time tracking of drug release from nanomedicine in vivo is crucial for optimizing its therapeutic efficacy in clinical settings, particularly in dosage control and determining the optimal therapeutic window. However,...
5.
He D, Cui B, Lv H, Lu S, Zhu Y, Cheng Y, et al.
Biomolecules
. 2024 Jul;
14(7).
PMID: 39062561
Cancer poses a significant public health challenge worldwide, and timely screening has the potential to mitigate cancer progression and reduce mortality rates. Currently, early identification of most tumors relies on...
6.
Bao L, Sun Z, Dang L, Zhang Q, Zheng L, Yang F, et al.
Cytotechnology
. 2024 Jun;
76(4):425-439.
PMID: 38933868
Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-024-00624-3.
7.
Qi H, Ge T, Wang K, Wang J, Dang L, Li J, et al.
Cell Biochem Biophys
. 2024 May;
82(2):987-996.
PMID: 38722470
Percutaneous coronary intervention (PCI) is the main treatment for patients with severe coronary vascular stenosis. However, In-stent neo-atherosclerosis (ISNA) is an important clinical complication in patients after PCI, which is...
8.
Li Y, Dang L, Lv C, Lin B, Tao J, Yu N, et al.
Drug Saf
. 2024 Apr;
47(7):711-719.
PMID: 38689136
Introduction: Ixekizumab, a monoclonal antibody against interleukin-17A, is efficacious and well tolerated for the treatment of moderate-to-severe plaque psoriasis. However, there are limited data on the real-world safety of ixekizumab...
9.
Li Y, Lv C, Dang L, Lin B, Tao J, Zhang C, et al.
Dermatol Ther (Heidelb)
. 2024 Mar;
14(4):907-918.
PMID: 38536616
Introduction: Ixekizumab, a monoclonal antibody against interleukin-17A, demonstrated effectiveness in the treatment of psoriasis in a Chinese real-world study that was consistent with previous randomized controlled trials. Here, we report...
10.
Zhang J, Dang L, Zhang F, Zhang K, Kong Q, Gu J
JACS Au
. 2023 Dec;
3(12):3424-3435.
PMID: 38155647
The low intrinsic thermal conduction and high dielectric properties of epoxy resins have significantly limited their applications in electrical and electronic devices with high integration, high frequency, high power, and...